These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37914282)

  • 21. Prescription Rates and Prognostic Implications of Optimally Targeted Guideline-Directed Medical Treatment in Heart Failure and Atrial Fibrillation: Insights From The MISOAC-AF Trial.
    Moysidis DV; Kartas A; Samaras A; Papazoglou AS; Patsiou V; Bekiaridou A; Baroutidou A; Tsagkaris C; Karagiannidis E; Daios S; Anastasiou V; Tsalikakis D; Efthimiadis G; Ziakas A; Tzikas A; Giannakoulas G
    J Cardiovasc Pharmacol; 2023 Mar; 81(3):203-211. PubMed ID: 36626410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction.
    Kocabaş U; Ergin I; Kıvrak T; Yılmaz Öztekin GM; Tanık VO; Özdemir İ; Avcı Demir F; Doğduş M; Şen T; Altınsoy M; Üstündağ S; Urgun ÖD; Sinan ÜY; Uygur B; Yeni M; Özçalık E
    ESC Heart Fail; 2023 Dec; 10(6):3677-3689. PubMed ID: 37804042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease.
    Cutshall BT; Duhart BT; Saikumar J; Samarin M; Hutchison L; Hudson JQ
    Am J Med Sci; 2018 Mar; 355(3):247-251. PubMed ID: 29549927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guideline-Directed Medical Therapy in Newly Diagnosed Heart Failure With Reduced Ejection Fraction in the Community.
    Dunlay SM; Killian JM; Roger VL; Schulte PJ; Blecker SB; Savitz ST; Redfield MM
    J Card Fail; 2022 Oct; 28(10):1500-1508. PubMed ID: 35902033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF).
    Savarese G; Kishi T; Vardeny O; Adamsson Eryd S; Bodegård J; Lund LH; Thuresson M; Bozkurt B
    JACC Heart Fail; 2023 Jan; 11(1):1-14. PubMed ID: 36202739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry.
    Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC
    J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization: EVOLUTION HF.
    Bozkurt B; Savarese G; Adamsson Eryd S; Bodegård J; Cleland JGF; Khordoc C; Kishi T; Thuresson M; Vardeny O; Zhang R; Lund LH
    JACC Heart Fail; 2023 Oct; 11(10):1320-1332. PubMed ID: 37354145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure.
    Tran RH; Aldemerdash A; Chang P; Sueta CA; Kaufman B; Asafu-Adjei J; Vardeny O; Daubert E; Alburikan KA; Kucharska-Newton AM; Stearns SC; Rodgers JE
    Pharmacotherapy; 2018 Apr; 38(4):406-416. PubMed ID: 29423950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year mortality and readmission rates in patients with heart failure in India: Results from the Trivandrum heart failure registry.
    Harikrishnan S; Jeemon P; Ganapathi S; Agarwal A; Viswanathan S; Sreedharan M; Vijayaraghavan G; Bahuleyan CG; Biju R; Nair T; Pratapkumar N; Krishnakumar K; Rajalekshmi N; Suresh K; Huffman MD
    Int J Cardiol; 2021 Mar; 326():139-143. PubMed ID: 33049297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of guideline-based medical therapy in patients with acute heart failure and reduced left ventricular ejection fraction: Observations from the Gulf acute heart failure registry (Gulf CARE).
    Jan RK; Alsheikh-Ali A; Mulla AA; Sulaiman K; Panduranga P; Al-Mahmeed W; Bazargani N; Al-Suwaidi J; Al-Jarallah M; Al-Motarreb A; Salam A; Al-Zakwani I
    Medicine (Baltimore); 2022 Jun; 101(23):e29452. PubMed ID: 35687781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction.
    Balakumaran K; Patil A; Marsh S; Ingrassia J; Kuo CL; Jacoby DL; Arora S; Soucier R
    Int J Cardiol Heart Vasc; 2019 Mar; 22():1-5. PubMed ID: 30480083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Incident Cancer.
    Tini G; Tanda S; Toma M; Battistoni A; Musumeci B; Barbato E; Canepa M; Ameri P
    Heart Lung Circ; 2024 May; 33(5):704-709. PubMed ID: 38609799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction.
    Driscoll A; Currey J; Tonkin A; Krum H
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009889. PubMed ID: 26689943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
    ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of guideline-directed medical therapy in patients with heart failure on regular hemodialysis.
    Kishihara M; Takada T; Jujo K; Shirotani S; Abe T; Yoshida A; Watanabe S; Hagiwara N
    Int J Cardiol; 2023 Jan; 370():250-254. PubMed ID: 36270495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry.
    Lainščak M; Milinković I; Polovina M; Crespo-Leiro MG; Lund LH; Anker SD; Laroche C; Ferrari R; Coats AJS; McDonagh T; Filippatos G; Maggioni AP; Piepoli MF; Rosano GMC; Ruschitzka F; Simić D; Ašanin M; Eicher JC; Yilmaz MB; Seferović PM;
    Eur J Heart Fail; 2020 Jan; 22(1):92-102. PubMed ID: 31863522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient Perceptions and Familiarity With Medical Therapy for Heart Failure.
    Samsky MD; Lin L; Greene SJ; Lippmann SJ; Peterson PN; Heidenreich PA; Laskey WK; Yancy CW; Greiner MA; Hardy NC; Kavati A; Park S; Mentz RJ; Fonarow GC; O'Brien EC
    JAMA Cardiol; 2020 Mar; 5(3):292-299. PubMed ID: 31734700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating Guideline Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction Post-coronary Artery Bypass Grafting.
    Kabulski GM; Boughner T; Szymanski TW; Sokos GG; Kido K
    J Pharm Pract; 2023 Dec; 36(6):1370-1374. PubMed ID: 35926866
    [No Abstract]   [Full Text] [Related]  

  • 39. Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial.
    Ghazi L; Yamamoto Y; Fuery M; O'Connor K; Sen S; Samsky M; Riello RJ; Dhar R; Huang J; Olufade T; McDermott J; Inzucchi SE; Velazquez EJ; Wilson FP; Desai NR; Ahmad T
    Eur Heart J; 2023 Oct; 44(40):4233-4242. PubMed ID: 37650264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
    Pandey A; Golwala H; DeVore AD; Lu D; Madden G; Bhatt DL; Schulte PJ; Heidenreich PA; Yancy CW; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2016 Aug; 4(8):649-61. PubMed ID: 27179827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.